Cargando…

An Improved Quantitative Approach for the Assessment of Mitochondrial Fragmentation in Chemoresistant Ovarian Cancer Cells

Mitochondrial fission is a process that involves cleavage of mitochondria into smaller fragments and is regulated by the GTPase Dynamin-related protein 1 (Drp1). Higher levels of mitochondrial fission are associated with the induction of apoptosis in cancer cells. However, current methods to accurat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Farrand, Lee, Kim, Ji Young, Im-Aram, Akechai, Suh, Jeong-Yong, Lee, Hyong Joo, Tsang, Benjamin K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3767598/ https://www.ncbi.nlm.nih.gov/pubmed/24040144 http://dx.doi.org/10.1371/journal.pone.0074008

Ejemplares similares

The Diarylheptanoid Hirsutenone Sensitizes Chemoresistant Ovarian Cancer Cells to Cisplatin via Modulation of Apoptosis-inducing Factor and X-linked Inhibitor of Apoptosis
por: Farrand, Lee, et al.
Publicado: (2014)

Molecular determinants of ovarian cancer chemoresistance: new insights into an old conundrum
por: Ali, Ahmed Y, et al.
Publicado: (2012)

The mTORC2 Component Rictor Contributes to Cisplatin Resistance in Human Ovarian Cancer Cells
por: Im-aram, Akechai, et al.
Publicado: (2013)

Chemoresistance in human ovarian cancer: the role of apoptotic regulators
por: Fraser, Michael, et al.
Publicado: (2003)

Phytochemicals: A Multitargeted Approach to Gynecologic Cancer Therapy
por: Farrand, Lee, et al.
Publicado: (2014)

Exosomal Plasma Gelsolin Is an Immunosuppressive Mediator in the Ovarian Tumor Microenvironment and a Determinant of Chemoresistance
por: Onuma, Toshimichi, et al.
Publicado: (2022)

Proton pump inhibitors enhance the effects of cytotoxic agents in chemoresistant epithelial ovarian carcinoma
por: Lee, Yoo-Young, et al.
Publicado: (2015)

Mitochondrial determinants of chemoresistance
por: Bokil, Ansooya, et al.
Publicado: (2019)

Tumor evolution and chemoresistance in ovarian cancer
por: Kim, Soochi, et al.
Publicado: (2018)

Possible Roles of Mitochondrial Dynamics and the Effects of Pharmacological Interventions in Chemoresistant Ovarian Cancer
por: Kingnate, Chalita, et al.
Publicado: (2018)

The exosome-mediated autocrine and paracrine actions of plasma gelsolin in ovarian cancer chemoresistance
por: Asare-Werehene, Meshach, et al.
Publicado: (2019)

Epigenetic Therapies as a Promising Strategy for Overcoming Chemoresistance in Epithelial Ovarian Cancer
por: Suh, Dong Hoon, et al.
Publicado: (2013)

Saikosaponin-d, a calcium mobilizing agent, sensitizes chemoresistant ovarian cancer cells to cisplatin-induced apoptosis by facilitating mitochondrial fission and G2/M arrest
por: Tsuyoshi, Hideaki, et al.
Publicado: (2017)

Chloroquine reverses chemoresistance via upregulation of p21(WAF1/CIP1) and autophagy inhibition in ovarian cancer
por: Hwang, Jae Ryoung, et al.
Publicado: (2020)

Prohibitin 1 interacts with p53 in the regulation of mitochondrial dynamics and chemoresistance in gynecologic cancers
por: Kong, Bao, et al.
Publicado: (2022)

Activation of LXRɑ/β by cholesterol in malignant ascites promotes chemoresistance in ovarian cancer
por: Kim, Soochi, et al.
Publicado: (2018)

Comparing SILAC- and Stable Isotope Dimethyl-Labeling Approaches for Quantitative Proteomics
por: Lau, Ho-Tak, et al.
Publicado: (2014)

Adipocytes promote ovarian cancer chemoresistance
por: Yang, Jiang, et al.
Publicado: (2019)

MicroRNAs overexpressed in ovarian ALDH1-positive cells are associated with chemoresistance
por: Park, Young Tae, et al.
Publicado: (2013)

Genetic Profiles Associated with Chemoresistance in Patient-Derived Xenograft Models of Ovarian Cancer
por: Li, Lan Ying, et al.
Publicado: (2019)

Comparing the Secretomes of Chemorefractory and Chemoresistant Ovarian Cancer Cell Populations
por: Lee, Amy H., et al.
Publicado: (2022)

PRIMA-1 increases cisplatin sensitivity in chemoresistant ovarian cancer cells with p53 mutation: a requirement for Akt down-regulation
por: Kobayashi, Noriko, et al.
Publicado: (2013)

PGC1α induced by reactive oxygen species contributes to chemoresistance of ovarian cancer cells
por: Kim, Boyun, et al.
Publicado: (2017)

Plasma Gelsolin Confers Chemoresistance in Ovarian Cancer by Resetting the Relative Abundance and Function of Macrophage Subtypes
por: Asare-Werehene, Meshach, et al.
Publicado: (2022)

microRNA-488 inhibits chemoresistance of ovarian cancer cells by targeting Six1 and mitochondrial function
por: Yang, Zhuo, et al.
Publicado: (2017)

Targeting Mitochondria for Treatment of Chemoresistant Ovarian Cancer
por: Emmings, Edith, et al.
Publicado: (2019)

Chemoresistance and targeted therapies in ovarian and endometrial cancers
por: Brasseur, Kevin, et al.
Publicado: (2016)

Bioenergetic Adaptations in Chemoresistant Ovarian Cancer Cells
por: Dar, Sajad, et al.
Publicado: (2017)

Bevacizumab as adjunct to chemotherapy for chemoresistant ovarian cancer
por: Hamilton, Gerhard
Publicado: (2020)

Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion
por: Tian, Wanjia, et al.
Publicado: (2022)

HOXB9 Overexpression Confers Chemoresistance to Ovarian Cancer Cells by Inducing ERCC-1, MRP-2, and XIAP
por: Suh, Dong Hoon, et al.
Publicado: (2023)

Malformin-A1 (MA1) Sensitizes Chemoresistant Ovarian Cancer Cells to Cisplatin-Induced Apoptosis
por: Abdullah, Nada, et al.
Publicado: (2021)

Exosomes secreted by chemoresistant ovarian cancer cells promote angiogenesis
por: Li, Zhang, et al.
Publicado: (2021)

Glioblastoma chemoresistance: roles of the mitochondrial melatonergic pathway
por: Anderson, George
Publicado: (2020)

Expression of Mitochondrial Regulators PGC1α and TFAM as Putative Markers of Subtype and Chemoresistance in Epithelial Ovarian Carcinoma
por: Gabrielson, Marike, et al.
Publicado: (2014)

MICU1 drives glycolysis and chemoresistance in ovarian cancer
por: Chakraborty, Prabir K., et al.
Publicado: (2017)

Leptin contributes to the taxol chemoresistance in epithelial ovarian cancer
por: Gu, Fei, et al.
Publicado: (2019)

Chemoresistance is mediated by ovarian cancer leader cells in vitro
por: Karimnia, Nazanin, et al.
Publicado: (2021)

Targeting BMI1 mitigates chemoresistance in ovarian cancer
por: Dey, Anindya, et al.
Publicado: (2022)

The deubiquitinase USP11 promotes ovarian cancer chemoresistance by stabilizing BIP
por: Zhu, Xiaolin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_he634rh0t6tdcnio2hn0jp4aj6